Your current location is set to United States. If this is incorrect, please change your location:
Canada has one of the highest rates of multiple sclerosis (MS) in the world, with an estimated 90,000 Canadians living with the disease. On average, 12 Canadians are diagnosed with MS everyday. Most people are diagnosed with MS between the ages of 20 and 49 and the unpredictable effects of the disease will last for the rest of their lives.
MS is a chronic autoimmune disease of the central nervous system. Since that includes the brain, spinal cord and optic nerve, MS can affect vision, memory, balance and mobility. It is considered an episodic disability meaning that the severity and duration of illness and disability can vary and are often followed by periods of wellness. It can also be progressive.
The disease attacks myelin, the protective covering of the nerves, causing inflammation and often damaging the myelin. Myelin is necessary for the transmission of nerve impulses through nerve fibres. If damage to myelin is slight, nerve impulses travel with minor interruptions; however, if damage is substantial and if scar tissue replaces the myelin, nerve impulses may be completely disrupted, and the nerve fibres themselves can be damaged.
MS is unpredictable and may cause symptoms such as extreme fatigue, lack of coordination, weakness, tingling, impaired sensation, vision problems, bladder problems, cognitive impairment and mood changes. Its effects can be physical, emotional and financial. Currently there is no cure, but each day researchers are learning more about what causes MS and are zeroing in on ways to prevent it.
We are here to help. No one needs to face MS alone. In communities across Canada, the MS Society provides information, support, educational events and other resources for people living with MS and their families. Learn more about the programs and services we offer.
Researchers funded by the MS Society are working to find the cause of MS, develop better treatments with less side effects, and ultimately cure the disease for everyone who is affected by it. Learn more about the research we fund.
Despite decades of research, the cause of MS remains a mystery. The best current evidence suggests that lifestyle, environmental, genetic and biological factors all contribute. All these areas are being actively examined. Studies funded by the MS Society are asking if certain risk factors, such as gender, age, family history or lifestyle habits impact a person’s susceptibility to MS.
60% of adults diagnosed with MS are between the ages of 20 and 49 years old. While it is most often diagnosed in adults aged 20 to 49, younger children and older adults are also diagnosed with the disease. In Canada, 43 is the average age of MS diagnosis. 75% of people in Canada living with MS are women. Women are three times more likely to be diagnosed with MS than men.
MS often develops slowly, and the symptoms may not appear right away. Upon initial symptoms, a person’s family doctor will refer him or her to a neurologist, who will conduct a full medical history and a neurological examination to assess things like eye movement, strength and coordination. To reach a confirmed diagnosis of MS, the neurologist may employ additional tests, such as a Magnetic Resonance Imaging (MRI) scan which looks for tissue damage in the brain.
The severity of MS, progression and specific symptoms cannot be predicted at the time of diagnosis.
Read more information for those newly diagnosed with MS.
No. Everyone’s experience with MS is different. In addition, MS is divided into several types, depending on the pattern of the individual’s disease:
Relapsing Remitting MS (RRMS) – Characterized by
unpredictable but clearly defined periods during which symptoms
are apparent. These ‘’relapses” are also known as episodes,
attacks, exacerbations, or flare-ups. Relapses can last for
varying periods (from a few days to several months) and are
followed by periods of recovery, or ‘remission’ during which
many functions return. About 85% of people are diagnosed with
this form of MS.
Some people with RRMS will eventually
transition to a state in which relapses and remissions no
longer occur. Symptoms may persist and disability slowly and
continually increases. This is referred to as secondary
progressive MS (SPMS).
Individuals who accumulate disability and experience worsening of symptoms right from the start are diagnosed with primary progressive MS.
Learn more about the various types of
MS is thought to be an autoimmune disease, which means the immune system - designed to protect against intruders such as viruses and bacteria - attacks tissues in the body. In the case of MS, the tissue that is targeted is myelin. Without myelin the communication between nerve cells is disrupted, and the body does not receive the instructions necessary to perform basic functions like speaking, seeing, walking and learning. Myelin damage can also lead to deterioration of the exposed nerves, resulting in irreversible damage to them. As a chronic neurological disease, MS can also have a dramatic effect on energy levels, sleep and overall quality of life. Learn more about the symptoms of MS here.
No. MS is not fatal for the vast majority of people living with the disease. Most people who have MS can expect a normal or near-normal lifespan, thanks to improvements in symptom management and the MS disease-modifying therapies.
Absolutely. Researchers are zeroing in on what causes MS and exploring ways to repair the damage it causes and ways to prevent MS from occurring. The MS Society of Canada and its related MS Scientific Research Foundation fund investigation into many aspects of the disease including:
Learn more about the latest news in MS research .